IVAMID

Inventiva S.A.

HealthcareBiotechnology
$4.56
$0.01(+16.92%)
52W$2.85
$7.98
Updated Jul 8, 02:00 AM
RSI47
RS Rating16/99
Beta1.63
Volatility84%
F-Score4/9
Mkt Cap$2.9B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Inventiva S.A. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is weak (RS Rating: 16), showing significant lag compared to the market leaders. Earnings growth of 89% provides fundamental context to the price action. Investors should exercise caution due to high volatility (84% annualized), which requires wider risk management.

Relative Strength
16
out of 99
Lagging
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.63
vs S&P 500
HIGH BETA
52W Position
33%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$4.54
50 SMA > 100 SMA$5.25
100 SMA > 150 SMA$5.24
150 SMA > 200 SMA$5.18

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$3.74+22.04%ABOVE
50 SMA$4.54+0.44%ABOVE
100 SMA$5.25-13.13%BELOW
150 SMA$5.24-13.04%BELOW
200 SMA$5.18-11.91%BELOW

Price Performance

1D+16.9%
1W+20.6%
1M+16.6%
3M-14.6%
6M-10.6%
YTD-4.2%
1Y+51.0%
3Y+5.2%
52-Week Trading Range33% from low
$4.56
52W Low$2.85
52W High$7.98

Technical Indicators

RSI (14)NEUTRAL
47.2
305070
Setup ScoreCOOL
1/10
Base depth: 59.4%

Risk Profile

Beta
1.63
52W Vol
84%
ATR
$0.19
Max DD (1Y)
-52%

Volume Analysis

Today
2.87M
50D Avg
833.4K
Vol Ratio
3.44x
Liquidity
ILLIQUID

Earnings Momentum

Q2'24-31%
$-0.94
Q4'24-341%
$-2.60
Q2'25-24%
$-1.62
Q4'25+75%
$-0.28
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:-0.83%
5 Years:+64.51%
3 Years:-28.33%
TTM:-64.61%

Compounded Profit Growth

10 Years:-7.54%
5 Years:
3 Years:
TTM:-45.07%

Stock Price CAGR

10 Years:-10.23%
5 Years:-20.46%
3 Years:+5.17%
1 Year:+50.99%

Return on Equity

10Y Avg:-247.7%
5Y Avg:-591.1%
3Y Avg:-1642.8%
Last Year:

Key Metrics

Market Cap$2.9B
Gross Margin33.7%
Net Margin-75.9%
Piotroski F-Score4/9

Frequently Asked Questions

Is IVA in an uptrend right now?

IVA has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is IVA overbought or oversold?

IVA's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.

Is IVA outperforming the market?

IVA has a Relative Strength (RS) Rating of 16 out of 99. IVA is currently lagging the broader market.

Where is IVA in its 52-week range?

IVA is trading at $4.56, which is 57% of its 52-week high ($7.98) and 33% above its 52-week low ($2.85).

How volatile is IVA?

IVA has a Beta of 1.63 and 52-week volatility of 84%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.